Y. Li

发表

Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol.

Sheng-yu Zhou, Xin Liu, Tao Wu, 2023, Future oncology.

Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis

Xin Liu, Xin Wang, S. Qi, 2023, Journal of hematology.

First-line immunochemotherapy for extranodal natural killer/T cell lymphoma.

S. Qi, Y. Li, 2024, The Lancet. Haematology.

Prediction of 5‐year overall survival of diffuse large B‐cell lymphoma on the pola‐R‐CHP regimen based on 2‐year event‐free survival and progression‐free survival

Shulian Wang, Yueping Liu, H. Jing, 2024, Cancer medicine.

Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma

Shulian Wang, Yueping Liu, H. Jing, 2024, Leukemia & lymphoma.

Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.

Yong-wen Song, Q. Zhong, S. Qi, 2024, Future oncology.

Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer

Q. Xue, Jianyang Wang, Zongmei Zhou, 2023, Frontiers in immunology.

Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis.

Shulian Wang, Yueping Liu, H. Jing, 2024, Cancer letters.

FLASH radiotherapy combined with immunotherapy: From biological mechanisms to blockbuster therapeutics

S. Qi, Y. Li, Yu Wang, 2025, Translational Oncology.

Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma

Yu-jing Zhang, Hua Wang, Ying Wang, 2024, Therapeutic advances in medical oncology.